Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KIO 201

Next Previous
X
Search
Drug Profile

KIO 201

Alternative Names: A crosslinked thiolated carboxymethyl hyaluronic acid 0.75% (CMHA-S); KIO 201; OBG; Ocular Bandage Gel - Kiora Pharmaceuticals; Thiolated hyaluronic acid topical drop

Latest Information Update: 28 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator EyeGate Pharma
  • Developer Kiora Pharmaceuticals
  • Class Eye disorder therapies; Polymers
  • Mechanism of Action Hyaluronic acid replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Corneal injuries
  • No development reported Dry eyes

Most Recent Events

  • 28 Jun 2024 No recent reports of development identified for phase-I development in Dry-eyes in USA (Ophthalmic, Gel)
  • 26 Mar 2024 KIO 201 is available for licensing as of 26 Mar 2024. https://kiorapharma.com/
  • 09 May 2023 Kiora Pharmaceuticals expects to receive Orphan Drug Designation for Corneal injuries in 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top